13, 14) treated with MTX-complicated sEBV+ CD8+ TCL died within 4 months, and another patient treated with MTX and TNF inhibitor (infliximab) (Case No. 18) showed CD8+ T-LPD with features of EBV− HLH. Here, CD8A is linked to hemophagocytic syndrome.